Global Porcine Epidemic Diarrhea Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Porcine Epidemic Diarrhea Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Segment by Application
1.3.1 Global Porcine Epidemic Diarrhea Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Porcine Epidemic Diarrhea Vaccines Market Size (2017-2028)
2.1.1 Global Porcine Epidemic Diarrhea Vaccines Revenue (2017-2028)
2.1.2 Global Porcine Epidemic Diarrhea Vaccines Sales (2017-2028)
2.2 Global Porcine Epidemic Diarrhea Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Regions (2017-2022)
2.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Regions (2017-2022)
2.3 Global Porcine Epidemic Diarrhea Vaccines Market Size Forecast by Region
2.3.1 Global Porcine Epidemic Diarrhea Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Porcine Epidemic Diarrhea Vaccines Regions (Countries) Ranking by Market Size
2.5 Porcine Epidemic Diarrhea Vaccines Market Dynamics
2.5.1 Porcine Epidemic Diarrhea Vaccines Market Trends
2.5.2 Porcine Epidemic Diarrhea Vaccines Market Drivers
2.5.3 Porcine Epidemic Diarrhea Vaccines Market Challenges
2.5.4 Porcine Epidemic Diarrhea Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Porcine Epidemic Diarrhea Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Porcine Epidemic Diarrhea Vaccines Sales in 2021
3.2 Global Top Manufacturers Porcine Epidemic Diarrhea Vaccines by Revenue
3.2.1 Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Porcine Epidemic Diarrhea Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Porcine Epidemic Diarrhea Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Porcine Epidemic Diarrhea Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Epidemic Diarrhea Vaccines as of 2021)
3.4 Global Porcine Epidemic Diarrhea Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Porcine Epidemic Diarrhea Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Porcine Epidemic Diarrhea Vaccines Market
3.7 Key Manufacturers Porcine Epidemic Diarrhea Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Porcine Epidemic Diarrhea Vaccines Market Size by Type
4.1 Global Porcine Epidemic Diarrhea Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Porcine Epidemic Diarrhea Vaccines Price by Type (2017-2022)
4.2 Global Porcine Epidemic Diarrhea Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Porcine Epidemic Diarrhea Vaccines Price Forecast by Type (2023-2028)
5 Global Porcine Epidemic Diarrhea Vaccines Market Size by Application
5.1 Global Porcine Epidemic Diarrhea Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Porcine Epidemic Diarrhea Vaccines Price by Application (2017-2022)
5.2 Global Porcine Epidemic Diarrhea Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Porcine Epidemic Diarrhea Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Porcine Epidemic Diarrhea Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Porcine Epidemic Diarrhea Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Company
6.1.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022)
6.1.2 North America Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022)
6.2 North America Porcine Epidemic Diarrhea Vaccines Market Size by Type
6.2.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
6.2.2 North America Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2028)
6.3 North America Porcine Epidemic Diarrhea Vaccines Market Size by Application
6.3.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
6.3.2 North America Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2028)
6.4 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country
6.4.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2028)
6.4.2 North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
6.4.3 the United States
6.4.4 Canada
7 Europe
7.1 Europe Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Company
7.1.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022)
7.1.2 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022)
7.2 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Type
7.2.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
7.2.2 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2028)
7.3 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Application
7.3.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
7.3.2 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2028)
7.4 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country
7.4.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2028)
7.4.2 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Type
8.2.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Application
8.3.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Region
8.4.1 Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region
8.4.2 Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Company
9.1.1 Latin America Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022)
9.2 Latin America Porcine Epidemic Diarrhea Vaccines Market Size by Type
9.2.1 Latin America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2028)
9.3 Latin America Porcine Epidemic Diarrhea Vaccines Market Size by Application
9.3.1 Latin America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2028)
9.4 Latin America Porcine Epidemic Diarrhea Vaccines Market Size by Country
9.4.1 Latin America Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size by Type
10.2.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size by Application
10.3.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country
10.4.1 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 CAVAC
11.1.1 CAVAC Corporation Information
11.1.2 CAVAC Overview
11.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Products and Services
11.1.5 CAVAC Porcine Epidemic Diarrhea Vaccines SWOT Analysis
11.1.6 CAVAC Recent Developments
11.2 Green Cross Veterinary Products
11.2.1 Green Cross Veterinary Products Corporation Information
11.2.2 Green Cross Veterinary Products Overview
11.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Products and Services
11.2.5 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines SWOT Analysis
11.2.6 Green Cross Veterinary Products Recent Developments
11.3 Harrisvaccines
11.3.1 Harrisvaccines Corporation Information
11.3.2 Harrisvaccines Overview
11.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Products and Services
11.3.5 Harrisvaccines Porcine Epidemic Diarrhea Vaccines SWOT Analysis
11.3.6 Harrisvaccines Recent Developments
11.4 Komipharm
11.4.1 Komipharm Corporation Information
11.4.2 Komipharm Overview
11.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Products and Services
11.4.5 Komipharm Porcine Epidemic Diarrhea Vaccines SWOT Analysis
11.4.6 Komipharm Recent Developments
11.5 Nisseiken
11.5.1 Nisseiken Corporation Information
11.5.2 Nisseiken Overview
11.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Products and Services
11.5.5 Nisseiken Porcine Epidemic Diarrhea Vaccines SWOT Analysis
11.5.6 Nisseiken Recent Developments
11.6 Qilu Animal Health
11.6.1 Qilu Animal Health Corporation Information
11.6.2 Qilu Animal Health Overview
11.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Products and Services
11.6.5 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines SWOT Analysis
11.6.6 Qilu Animal Health Recent Developments
11.7 Zoetis
11.7.1 Zoetis Corporation Information
11.7.2 Zoetis Overview
11.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Products and Services
11.7.5 Zoetis Porcine Epidemic Diarrhea Vaccines SWOT Analysis
11.7.6 Zoetis Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Porcine Epidemic Diarrhea Vaccines Value Chain Analysis
12.2 Porcine Epidemic Diarrhea Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Porcine Epidemic Diarrhea Vaccines Production Mode & Process
12.4 Porcine Epidemic Diarrhea Vaccines Sales and Marketing
12.4.1 Porcine Epidemic Diarrhea Vaccines Sales Channels
12.4.2 Porcine Epidemic Diarrhea Vaccines Distributors
12.5 Porcine Epidemic Diarrhea Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Porcine Epidemic Diarrhea Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Porcine Epidemic Diarrhea Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Porcine Epidemic Diarrhea Vaccines Sales by Region (2017-2022) & (K Units)
Table 7. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2017-2022)
Table 10. Global Porcine Epidemic Diarrhea Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Porcine Epidemic Diarrhea Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Porcine Epidemic Diarrhea Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Porcine Epidemic Diarrhea Vaccines Market Trends
Table 16. Porcine Epidemic Diarrhea Vaccines Market Drivers
Table 17. Porcine Epidemic Diarrhea Vaccines Market Challenges
Table 18. Porcine Epidemic Diarrhea Vaccines Market Restraints
Table 19. Global Porcine Epidemic Diarrhea Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Porcine Epidemic Diarrhea Vaccines Sales Share by Manufacturers (2017-2022)
Table 21. Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Porcine Epidemic Diarrhea Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 23. Porcine Epidemic Diarrhea Vaccines Revenue Share by Manufacturers (2017-2022)
Table 24. Global Porcine Epidemic Diarrhea Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Epidemic Diarrhea Vaccines as of 2021)
Table 26. Key Manufacturers Porcine Epidemic Diarrhea Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Porcine Epidemic Diarrhea Vaccines Plants/Factories Distribution
Table 28. Key Manufacturers Porcine Epidemic Diarrhea Vaccines Area Served
Table 29. Date of Key Manufacturers Enter into Porcine Epidemic Diarrhea Vaccines Market
Table 30. Key Manufacturers Porcine Epidemic Diarrhea Vaccines Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Porcine Epidemic Diarrhea Vaccines Sales (K Units) by Type (2017-2022)
Table 33. Global Porcine Epidemic Diarrhea Vaccines Sales Share by Type (2017-2022)
Table 34. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Porcine Epidemic Diarrhea Vaccines Price (K Units) by Type (2017-2022)
Table 36. Global Porcine Epidemic Diarrhea Vaccines Sales (K Units) by Type (2023-2028)
Table 37. Global Porcine Epidemic Diarrhea Vaccines Sales Share by Type (2023-2028)
Table 38. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Porcine Epidemic Diarrhea Vaccines Revenue Share by Type (2023-2028)
Table 40. Global Porcine Epidemic Diarrhea Vaccines Price (K Units) by Type (2023-2028)
Table 41. Global Porcine Epidemic Diarrhea Vaccines Sales (K Units) by Application (2017-2022)
Table 42. Global Porcine Epidemic Diarrhea Vaccines Sales Share by Application (2017-2022)
Table 43. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Porcine Epidemic Diarrhea Vaccines Price (K Units) by Application (2017-2022)
Table 45. Global Porcine Epidemic Diarrhea Vaccines Sales (K Units) by Application (2023-2028)
Table 46. Global Porcine Epidemic Diarrhea Vaccines Sales Share by Application (2023-2028)
Table 47. Global Porcine Epidemic Diarrhea Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Porcine Epidemic Diarrhea Vaccines Revenue Share by Application (2023-2028)
Table 49. Global Porcine Epidemic Diarrhea Vaccines Price (K Units) by Application (2023-2028)
Table 50. North America Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022) & (K Units)
Table 51. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Company (2017-2022)
Table 52. North America Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Company (2017-2022)
Table 54. North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. North America Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Porcine Epidemic Diarrhea Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 59. North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 60. North America Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Porcine Epidemic Diarrhea Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022) & (K Units)
Table 67. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Company (2017-2022)
Table 68. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Company (2017-2022)
Table 70. Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 75. Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 76. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2022) & (K Units)
Table 79. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2023-2028) & (K Units)
Table 80. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Company (2017-2022)
Table 100. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Company (2017-2022)
Table 102. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Porcine Epidemic Diarrhea Vaccines Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 130. CAVAC Corporation Information
Table 131. CAVAC Description and Overview
Table 132. CAVAC Porcine Epidemic Diarrhea Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
Table 134. CAVAC Porcine Epidemic Diarrhea Vaccines SWOT Analysis
Table 135. CAVAC Recent Developments
Table 136. Green Cross Veterinary Products Corporation Information
Table 137. Green Cross Veterinary Products Description and Overview
Table 138. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
Table 140. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines SWOT Analysis
Table 141. Green Cross Veterinary Products Recent Developments
Table 142. Harrisvaccines Corporation Information
Table 143. Harrisvaccines Description and Overview
Table 144. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
Table 146. Harrisvaccines Porcine Epidemic Diarrhea Vaccines SWOT Analysis
Table 147. Harrisvaccines Recent Developments
Table 148. Komipharm Corporation Information
Table 149. Komipharm Description and Overview
Table 150. Komipharm Porcine Epidemic Diarrhea Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
Table 152. Komipharm Porcine Epidemic Diarrhea Vaccines SWOT Analysis
Table 153. Komipharm Recent Developments
Table 154. Nisseiken Corporation Information
Table 155. Nisseiken Description and Overview
Table 156. Nisseiken Porcine Epidemic Diarrhea Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
Table 158. Nisseiken Porcine Epidemic Diarrhea Vaccines SWOT Analysis
Table 159. Nisseiken Recent Developments
Table 160. Qilu Animal Health Corporation Information
Table 161. Qilu Animal Health Description and Overview
Table 162. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
Table 164. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines SWOT Analysis
Table 165. Qilu Animal Health Recent Developments
Table 166. Zoetis Corporation Information
Table 167. Zoetis Description and Overview
Table 168. Zoetis Porcine Epidemic Diarrhea Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
Table 170. Zoetis Porcine Epidemic Diarrhea Vaccines SWOT Analysis
Table 171. Zoetis Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Porcine Epidemic Diarrhea Vaccines Distributors List
Table 175. Porcine Epidemic Diarrhea Vaccines Customers List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Epidemic Diarrhea Vaccines Product Picture
Figure 2. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type in 2021 & 2028
Figure 3. Live Vaccines Product Picture
Figure 4. Killed Vaccines Product Picture
Figure 5. Global Porcine Epidemic Diarrhea Vaccines Sales Market Shar

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs